glp 1 drugs sleep apnea GLP1 Help Protect Against Study Says Study finds GLP-1 drugs may

RosenstockJHansenLZeePLiYCookWHirshbergBet al

Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin [939] as a GLP-1 receptor antagonist

Eylea (aflibercept) Disease area(s): Ophthalmology Manufacturer(s): Regeneron/Bayer 2024 Sales (USD): $9.55 billion Why it sold so well: Eylea registered strong sales in 2024, driven by the introduction of Eylea HD, which received FDA approval in 2023 and is an 8 mg formulation offering extended dosing intervals for retinal diseases

It could explain why COVID-19 in these people has a more severe course, with higher vulnerability to cytokine storms and fulminant multi-organ failure

Importantly, these studies are unable to control for key confounders of cancer risk and this dataset is inherently prone to multiple types of bias